External Comparator Cohort studies - clarification of terminology

Gerd Rippin, Joan Largent, Wilhelmina Elisabeth Hoogendoorn, Héctor Sanz, Jaclyn Bosco, Christina Mack

Open source

DOI
10.3389/fdsfr.2023.1321894
Published
2024-01-24
Container
Frontiers in Drug Safety and Regulation
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fdsfr.2023.1321894,
  title = {External Comparator Cohort studies - clarification of terminology},
  author = {Gerd Rippin and Joan Largent and Wilhelmina Elisabeth Hoogendoorn and Héctor Sanz and Jaclyn Bosco and Christina Mack},
  year = {2024},
  journal = {Frontiers in Drug Safety and Regulation},
  doi = {10.3389/fdsfr.2023.1321894},
  url = {https://doi.org/10.3389/fdsfr.2023.1321894}
}

RIS

TY  - JOUR
TI  - External Comparator Cohort studies - clarification of terminology
AU  - Gerd Rippin
AU  - Joan Largent
AU  - Wilhelmina Elisabeth Hoogendoorn
AU  - Héctor Sanz
AU  - Jaclyn Bosco
AU  - Christina Mack
PY  - 2024
JO  - Frontiers in Drug Safety and Regulation
DO  - 10.3389/fdsfr.2023.1321894
UR  - https://doi.org/10.3389/fdsfr.2023.1321894
ER  - 

APA

Rippin, G., Largent, J., Hoogendoorn, W. E., Sanz, H., Bosco, J., & Mack, C. (2024). External Comparator Cohort studies - clarification of terminology. Frontiers in Drug Safety and Regulation. https://doi.org/10.3389/fdsfr.2023.1321894

Source records